The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism
Open accessAbstract
Insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) is known to block IGF action and inhibit cell growth. IGFBP-3 is thought to act by sequestering free IGFs or, possibly, act via a novel IGF-independent mechanism. Supporting its role as a primary growth inhibitor, IGFBP-3 production has been shown to be increased by cell growth-inhibitory agents, such as transforming growth factor-beta (TGF-beta), and the tumor suppressor gene p53. In this paper, we demonstrate, for the first time, a novel function of IGFBP-3 as an apoptosis-inducing agent and show that this action is mediated through an IGF.IGF receptor-independent pathway. In the p53 negative prostate cancer cell line, PC-3, the addition of recombinant IGFBP-3 resulted in a dose-dependent induction of apoptosis. 125I-IGFBP-3 bound with high affinity to specific proteins in PC-3 cell lysates and plasma membrane preparations. These membrane-associated molecules may serve as receptors that mediate the direct effect of IGFBP-3 on apoptosis. In addition, in an IGF receptor-negative mouse fibroblast cell line, treatment with recombinant IGFBP-3 as well as transfection of the IGFBP-3 gene induced apoptosis, suggesting that neither IGFs nor IGF receptors are required for this action. Furthermore, treatment with TGF-beta1, a known apoptosis-inducing agent, resulted in the induction of IGFBP-3 expression 6-12 h before the onset of apoptosis. This effect of TGF-beta1 was prevented by co-treatment with IGFBP-3-neutralizing antibodies or IGFBP-3-specific antisense thiolated oligonucleotides. These findings suggest that IGFBP-3 induces apoptosis through a novel pathway independent of either p53 or the IGF.IGF receptor-mediated cell survival pathway and that IGFBP-3 mediates TGF-beta1 induced apoptosis in PC-3 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutellingsperger, C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00072-i · Cited by 5,410
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product
Tewari, M., & Dixit, V. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3255 · Cited by 596
Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., & Baserga, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11217 · Cited by 553
Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H., Krajewski, S., Reed, J., Hoffman‐Liebermann, B., & Liebermann, D. A. (1994) · PubMed · Cited by 478
Oh, Y., Müller, H. L., Lamson, G., & Rosenfeld, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82426-7 · Cited by 472
Homburg, C., de Haas, M., von dem Borne, A., Verhoeven, A., Reutelingsperger, C., & Roos, D. (1995) · Blood · doi:10.1182/blood.v85.2.532.532 · Cited by 431
Werner, H., Karnieli, E., Rauscher, F. J., & LeRoith, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8318 · Cited by 370
Cited by
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*
Hwa, V., Oh, Y., & Rosenfeld, R. G. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0382 · Cited by 1,079
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
Giovannucci, E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3109s · Cited by 959
Regulation ofp53downstream genes
El-Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 800
Baxter, R. C. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.6.e967 · Cited by 672
The emerging roles of human tissue kallikreins in cancer
Borgoño, C. A., & Diamandis, E. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1474 · Cited by 650
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
Kaaks, R., & Lukanova, A. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200070 · Cited by 615
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Oxidative stress in prostate cancer
Khandrika, L., Kumar, B., Koul, S., Maroni, P., & Koul, H. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.011 · Cited by 527
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
Self-citationChan, J. M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.14.1099 · Cited by 433
Prieur, A., Tirode, F., Cohen, P., & Delattre, O. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7275-7283.2004 · Cited by 420
Self-citationMechanisms of TGF-β-mediated apoptosis
Schuster, N., & Krieglstein, K. (2002) · Cell and Tissue Research · doi:10.1007/s00441-001-0479-6 · Cited by 400
Glycemic index in chronic disease: a review
Augustin, L., Franceschi, S., Jenkins, D., Kendall, C., & La Vecchia, C. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601454 · Cited by 390
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371
Bubendorf, L., Kolmer, M., Kononen, J., Koivisto, P., Mousses, S., Chen, Y., Mahlamaki, E., Schraml, P., Moch, H., Willi, N., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.20.1758 · Cited by 350
Liu, B., Lee, H.-Y., Weinzimer, S. A., Powell, D. R., Clifford, J. L., Kurie, J. M., & Cohen, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002547200 · Cited by 326
Self-citationUnraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Jogie-Brahim, S., Feldman, D., & Oh, Y. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0028 · Cited by 323
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080197 · Cited by 314
Role of the Crosstalk between Autophagy and Apoptosis in Cancer
Su, M., Mei, Y., & Sinha, S. (2013) · Journal of Oncology · doi:10.1155/2013/102735 · Cited by 306
Mechanisms of p53-mediated apoptosis
Bates, S., & Vousden, K. H. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050267 · Cited by 305
Insulin-like growth factor physiology and cancer risk
Pollak, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00102-7 · Cited by 296
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
Richardson, L. C., & Pollack, L. A. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0062 · Cited by 289
104 candidate genes for the hypoxic tumor phenotype
Koong, A. C., Denko, N. O., Schindler, C., Le, Q. T., Terris, D. T., Ibrahim, H. Z., Goffinet, D. R., & Giaccia, A. J. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)90122-0 · Cited by 285
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
Schedlich, L. J., Le Page, S. L., Firth, S. M., Briggs, L. J., Jans, D. A., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002208200 · Cited by 280
Ikonen, M., Liu, B., Hashimoto, Y., Ma, L., Lee, K.-W., Niikura, T., Nishimoto, I., & Cohen, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135111100 · Cited by 279
Self-citationSchedlich, L. J., Young, T. F., Firth, S. M., & Baxter, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18347 · Cited by 272
Rajpathak, S. N., Gunter, M. J., Wylie‐Rosett, J., Ho, G. Y. F., Kaplan, R. C., Muzumdar, R., Rohan, T. E., & Strickler, H. D. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.919 · Cited by 265
Platz, E. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2009 · Cited by 255
Velasco-Miguel, S., Buckbinder, L., Jean, P., Gelbert, L., Talbott, R., Laidlaw, J., Seizinger, B., & Kley, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202274 · Cited by 252
Miyake, H., Nelson, C., Rennie, P. S., & Gleave, M. E. (2000) · Endocrinology · doi:10.1210/endo.141.6.7520 · Cited by 146
Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes
Chan, S. S. Y., Twigg, S. M., Firth, S. M., & Baxter, R. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0595 · Cited by 84
E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis
Lou, Z., & Wang, S. (2014) · Journal of International Medical Research · doi:10.1177/0300060513506655 · Cited by 22
Metadata
- Authors
- Rajah, R., Valentinis, B., & Cohen, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-05
- Volume
- 272
- Issue
- 18
- Pages
- 12181-12188
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2077956417
- Cited by
- 722
- References
- 39
- FWCI
- 35.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.